HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancer.

Authors
JournalEuropean journal of cancer (Eur J Cancer (1965)) Vol. 8 Issue 2 Pg. 157-8 (Apr 1972) ISSN: 0014-2964 [Print] England
PMID4561334 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Imides
  • Morpholines
  • Piperidines
  • 1-(morpholinomethyl)-4-phthalimidopiperidine-2,6- dione
Topics
  • Administration, Oral
  • Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Clinical Trials as Topic
  • Female
  • Humans
  • Imides (administration & dosage, adverse effects, therapeutic use)
  • Menopause
  • Morpholines (administration & dosage, adverse effects, therapeutic use)
  • Nausea (chemically induced)
  • Piperidines (administration & dosage, adverse effects, therapeutic use)
  • Remission, Spontaneous
  • Vomiting (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: